Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents

被引：80

作者：

Cuenca-Estrella, M ^{[1
]}

Gomez-Lopez, A ^{[1
]}

Mellado, E ^{[1
]}

Buitrago, MJ ^{[1
]}

Monzón, A ^{[1
]}

Rodriguez-Tudela, JL ^{[1
]}

机构：

[1] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Micol, Madrid 28220, Spain

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2003年 / 47卷 / 07期

关键词：

D O I：

10.1128/AAC.47.7.2339-2341.2003

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The antifungal susceptibility results for 32 clinical isolates of Scopulariopsis brevicaulis are presented. Flucytosine and itraconazole were inactive in vitro, and MICs of amphotericin B, voriconazole, and terbinafine for all isolates were high, with geometric means of 13, 25.8, and 14.4 mug/ml, respectively.

引用

页码：2339 / 2341

页数：3

共 22 条

[1] Comparative evaluation of two different methods of inoculum preparation for antifungal susceptibility testing of filamentous fungi
Aberkane, A
Cuenca-Estrella, M
Gomez-Lopez, A
Petrikkou, E
Mellado, E
Monzón, A
Rodriguez-Tudela, JL
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (05) : 719 - 722
[2] In vitro antifungal susceptibilities of Scopulariopsis isolates
Aguilar, C
Pujol, I
Guarro, J
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (06) : 1520 - 1522
[3] Granulomatous skin infection caused by Scopulariopsis brevicaulis
Bruynzeel, I
Starink, TM
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 39 (02) : 365 - 367
[4] Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection
Denning, DW
Radford, SA
Oakley, KL
Hall, L
Johnson, EM
Warnock, DW
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (03) : 401 - 414
[5] SCOPULARIOPSIS-BREVICAULIS SKIN-LESIONS IN AN AIDS PATIENT
DHAR, J
CAREY, PB
[J]. AIDS, 1993, 7 (09) : 1283 - 1284
[6] Scopulariopsis fungus ball
Endo, S
Hironaka, M
Murayama, F
Yamaguchi, T
Sohara, Y
Saito, K
[J]. ANNALS OF THORACIC SURGERY, 2002, 74 (03) : 926 - 927
[7] Gariano RF, 1997, RETINA-J RET VIT DIS, V17, P256
[8] GENTRY LO, 1995, TEX HEART I J, V22, P81
[9] In vitro activity of Syn-2869, a novel triazole agent, against emerging and less common mold pathogens
Johnson, EM
Szekely, A
Warnock, DW
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (05) : 1260 - 1263
[10] Kwon-Chung K, 1992, MED MYCOL, P733

← 1 2 3 →